Open AccessPlasma S100A12 Level Is Associated with Cardiovascular Disease in Hemodialysis Patients
Author(s) -
Yayoi Shiotsu,
Yoshihide Mori,
Masato Nishimura,
Chikako Sakoda,
Toshiko Tokoro,
Tsuguru Hatta,
Norio Maki,
Kumiko Iida,
Noriyuki Iwamoto,
Toshihiko Ono,
Eiko Matsuoka,
Noriko Kishimoto,
Keiichi Tamagaki,
Hiroaki Matsubara,
Atsushi Kosaki
Publication year - 2011
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.08310910
Subject(s) - medicine , hemodialysis , odds ratio , diabetes mellitus , confidence interval , disease , kidney disease , cross sectional study , type 2 diabetes , logistic regression , gastroenterology , endocrinology , pathology
S100A12 is an endogenous receptor ligand for advanced glycation end products. Cardiovascular disease remains a major cause of morbidity and mortality in patients with chronic kidney disease. In this study, we report cross-sectional data on 550 hemodialysis patients and assess the relationship between plasma S100A12 level and cardiovascular disease.